Research Article
FASN Protein Overexpression Indicates Poor Biochemical Recurrence-Free Survival in Prostate Cancer
Table 3
Univariate and multivariate analyses of survival of FASN expression.
| | Univariate analysis | Multivariate analysis | | HR (95% CI) | value | HR (95% CI) | value |
| | FASN (high/low) | 1.717 (1.132-2.604) | 0.011 | 2.005 (1.248-3.221) | 0.004 | | PSA level (>10/≤10) | 3.060 (1.675-5.589) | <0.001 | 2.903 (1.486-5.669) | 0.002 | | Gleason score (≥8/<8) | 3.122 (2.125-4.587) | <0.001 | 2.375 (1.493-3.778) | <0.001 | | pT category (T3+T4/T2) | 2.951 (2.023-4.305) | <0.001 | 1.503 (0.912-2.477) | 0.110 | | pN category (pN1/pN0) | 4.083 (2.573-6.477) | <0.001 | 3.024 (1.846-4.953) | <0.001 | | Age (>70/≤70) | 0.792 (0.531-1.181) | 0.253 | | |
|
|